+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Companion Diagnostics"

Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032 - Product Thumbnail Image

Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032

  • Report
  • February 2024
  • 82 Pages
  • Asia Pacific
From
Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Coagulation, Molecular Diagnostics) By Application, End-use, Country, and Segment Forecasts, 2023-2030 - Product Thumbnail Image

Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Coagulation, Molecular Diagnostics) By Application, End-use, Country, and Segment Forecasts, 2023-2030

  • Report
  • December 2023
  • 85 Pages
  • Europe
From
United States In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

United States In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 82 Pages
  • United States
From
Asia Pacific In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Asia Pacific In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 92 Pages
  • Asia Pacific
From
Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Thumbnail Image

Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • January 2024
  • 121 Pages
  • Asia Pacific
From
Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations (December 9-12, 2024) - Product Thumbnail Image

Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations (December 9-12, 2024)

  • Conference
  • December 2024
  • 4 Days
  • Europe
Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations (July 22-25, 2024) - Product Thumbnail Image

Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations (July 22-25, 2024)

  • Conference
  • July 2024
  • 4 Days
  • Europe
Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review - Product Thumbnail Image

Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review

  • Report
  • May 2024
  • Global
From
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Product Thumbnail Image

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

  • Report
  • June 2020
  • 464 Pages
  • Global
From
Companion Diagnostics Development Services Market: Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Companion Diagnostics Development Services Market: Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • March 2022
  • 405 Pages
  • Global
From
Companion Diagnostics Market (2nd Edition), 2019-2030 - Product Thumbnail Image

Companion Diagnostics Market (2nd Edition), 2019-2030

  • Report
  • April 2019
  • 300 Pages
  • Global
From
United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition - Product Thumbnail Image

United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition

  • Report
  • October 2022
  • 220 Pages
  • United States
From
The World Market for Cancer Diagnostics, 2021 - Product Thumbnail Image

The World Market for Cancer Diagnostics, 2021

  • Report
  • December 2021
  • 347 Pages
  • Global
From
Molecular Diagnostics Markets in the COVID-19 Era (Markets for Molecular COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests) - Product Thumbnail Image

Molecular Diagnostics Markets in the COVID-19 Era (Markets for Molecular COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests)

  • Report
  • July 2020
  • 300 Pages
  • Global
From
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities - Product Thumbnail Image

Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

  • Report
  • June 2020
  • 180 Pages
  • Global
From
Molecular Cancer Diagnostics Market - Product Thumbnail Image

Molecular Cancer Diagnostics Market

  • Report
  • February 2020
  • 189 Pages
  • Global
From
IVD Procedure Volumes 2021-2026 - Product Thumbnail Image

IVD Procedure Volumes 2021-2026

  • Report
  • March 2022
  • 312 Pages
  • Global
From
IVD Market Brief Update - Product Thumbnail Image

IVD Market Brief Update

  • Report
  • November 2021
  • 39 Pages
  • Global
From
In Vitro Diagnostic Market Brief Update - Product Thumbnail Image

In Vitro Diagnostic Market Brief Update

  • Report
  • October 2021
  • 38 Pages
  • Global
From
In-vitro Diagnostics Global Market- Forecast to 2027 - Product Thumbnail Image

In-vitro Diagnostics Global Market- Forecast to 2027

  • Report
  • September 2021
  • 792 Pages
  • Global
From
Loading Indicator

The Companion Diagnostics market is a subset of the biotechnology industry that focuses on the development and commercialization of diagnostic tests that are used to identify patients who are likely to benefit from a particular therapeutic. These tests are used to identify the presence of a specific biomarker or genetic mutation that is associated with a particular therapeutic. The Companion Diagnostics market is driven by the increasing demand for personalized medicine, which is tailored to the individual patient's genetic makeup. This has led to the development of more sophisticated tests that can detect a wider range of biomarkers and mutations. The Companion Diagnostics market is highly competitive, with a number of companies offering a range of tests. Examples of companies in the market include Roche Diagnostics, Abbott Laboratories, Qiagen, Illumina, and Thermo Fisher Scientific. Show Less Read more